scholarly journals Double Blind Clinical Studies of Fenbufen for Upper Respiratory Tract Inflammation

1978 ◽  
Vol 71 (1) ◽  
pp. 45-63
Author(s):  
Shuji Sawaki ◽  
Toshiki Manabe ◽  
Yasushi Ishibashi ◽  
Kurata Yuge ◽  
Kenichi Nakamura ◽  
...  
Keyword(s):  
Respiratory Tract ◽  
Clinical Studies ◽  
Upper Respiratory Tract ◽  
Double Blind ◽  
Upper Respiratory ◽  
Respiratory Tract Inflammation

scholarly journals A Double-Blind Clinical Evaluation of Flurbiprofen on Acute Upper Respiratory Tract Inflammation

1984 ◽  
Vol 58 (12) ◽  
pp. 1289-1304 ◽  
Author(s):  
Masao TAMURA ◽  
Takashi ITO ◽  
Morio SUDO ◽  
Minoru TAZAWA ◽  
Tsuneo SAYAMA ◽  
...  
Keyword(s):  
Respiratory Tract ◽  
Clinical Evaluation ◽  
Upper Respiratory Tract ◽  
Double Blind ◽  
Upper Respiratory ◽  
Respiratory Tract Inflammation

A Placebo Controlled, Double-Blind Evaluation of Levamisole in the Reduction of the Frequency, Duration and Severity of Attacks in Children Suffering from Recurrent Upper Respiratory Tract Infections

1979 ◽  
Vol 7 (4) ◽  
pp. 302-304 ◽  
Author(s):  
F Dils
Keyword(s):  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Controlled Study ◽  
Upper Respiratory Tract ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Single Body ◽  
Upper Respiratory ◽  
Tract Infections ◽  
Adjusted Dose

In a double-blind placebo controlled study of levamisole in the treatment of children with recurrent upper respiratory tract infection (URI) eighty-six patients took part. Medication was given once a week, in a single body-weight adjusted dose. The children treated with levamisole had a statistically significantly reduced incidence of episodes of infection which were less severe, less prolonged and required less antibiotics. No side-effects were reported.

Sign in / Sign up

Export Citation Format

Share Document